Transcribed Image Text
Our typical valuation tools rely on either discounting futurecash flows of the firm or using multiples of EBITDA (based onobservable comparable firms).How well would these tools work if thefirm is many years away from positive free cash flow and currentlyhas negative EBITDA or has positive EBITDA but is expected to growmuch more quickly than observable comps?
Other questions asked by students
Medical Sciences
Mechanical Engineering
Calculus
Accounting